Acquirer
Ligand Pharmaceuticals
Ligand Pharmaceuticals appears as the named buyer in 12 recorded transactions between 2015 and 2024, most often in healthcare & life sciences. 1 of those was bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Ligand Pharmaceuticals has bought
Every recorded transaction where Ligand Pharmaceuticals is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Apeiron Biologics | Healthcare & Life Sciences | — | 2024-07-08 | $100m |
| Tolerance Therapeutics | Healthcare & Life Sciences | — | 2023-11-01 | $20m |
| Novan | Healthcare & Life Sciences | — | 2023-09-27 | $12m |
| xCella Biosciences | Healthcare & Life Sciences | — | 2020-09-10 | $7.0m |
| Taurus Biosciences LLC | Healthcare & Life Sciences | — | 2020-09-10 | $5.0m |
| Pfenex | Healthcare & Life Sciences | — | 2020-08-10 | $438m |
| Icagen | Healthcare & Life Sciences | Icagen | 2020-02-11 | $15m |
| Ab Initio Biotherapeutics | Healthcare & Life Sciences | — | 2019-07-23 | $12m |
| Vernalis | Healthcare & Life Sciences | — | 2018-08-09 | $50m |
| Crystal Bioscience | Healthcare & Life Sciences | — | 2017-10-04 | $25m |
| CorMatrix Cardiovascular | Healthcare & Life Sciences | CorMatrix Cardiovascular | 2016-05-04 | $18m |
| Open Monoclonal Technology | Healthcare & Life Sciences | EW Healthcare Partners PE | 2015-12-17 | $178m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.